Core Viewpoint - Harbin Pharmaceutical Group Co., Ltd. has announced that its subsidiary, Harbin Pharmaceutical Group Pharmaceutical Factory, has received approval from the National Medical Products Administration for the injection of Cefoperazone Sodium, which has passed the consistency evaluation of quality and efficacy for generic drugs [1][2]. Group 1: Drug Information - The drug, Cefoperazone Sodium for injection, is available in two specifications: 1.0g and 0.5g [1]. - It is indicated for infections caused by sensitive bacteria, including lower respiratory tract infections, urogenital infections, gynecological infections, bacteremia/sepsis, skin and soft tissue infections, abdominal infections, bone and joint infections, and central nervous system infections [2]. - As of the announcement date, there are 239 production approvals for Cefoperazone Sodium in China, with 37 manufacturers having passed the consistency evaluation [2]. - The projected annual sales for Cefoperazone Sodium in domestic hospitals for 2024 is estimated at 1.55 billion yuan, with sales of 889 million yuan recorded in the first three quarters of 2025 [2]. - The company has invested approximately 8.16 million yuan in the research and development of this drug's consistency evaluation project [2]. Group 2: Impact on the Company - The approval of the drug through the consistency evaluation will likely lead to increased support in medical insurance payments and procurement by medical institutions, enhancing the market share and competitiveness of the product [3]. - The experience gained from this evaluation will benefit the company's future efforts in conducting similar evaluations for other products [3].

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：601777 证券简称：千里科技 公告编号：2026-004 重庆千里科技股份有限公司 关于持股5%以上股东权益变动触及1%刻度暨股东减持股份结果公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏， 并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 股东持股基本情况 本次减持计划实施前，重庆千里科技股份有限公司（以下简称"公司"）股东重庆江河汇企业管理有限责 任公司（以下简称"江河汇"）持有公司无限售条件流通股份900,000,000股，占公司总股本的19.91%。 ● 减持计划的实施结果情况 2025年11月17日，公司披露了《重庆千里科技股份有限公司持股5%以上股东减持股份计划公告》（公 告编号：2025-093）。公司股东江河汇拟通过大宗交易方式向潜在优质投资人定向减持公司股份不超过 90,422,002股（占公司总股本的2%）。减持期间为自2025年12月8日至2026年3月7日。2026年2月10日， 公司收到股东江河汇出具的《关于减持计划减持结果暨权益变动比例触及1%刻度的通 ...

Core Viewpoint - The company has released its operational performance summary for January 2026, providing key metrics for investors to review [2]. Group 1 - The company emphasizes that the data presented may differ from those in regular reports due to various uncertainties, and the figures are considered preliminary and for reference only [3]. - The board of directors assures that the announcement does not contain any false records, misleading statements, or significant omissions, and they bear legal responsibility for the content's authenticity, accuracy, and completeness [1]. - The announcement was made by the board of directors on February 10, 2026 [4].

Sales Performance - In January 2026, the company achieved a sales revenue of 2.021 billion yuan, representing a year-on-year increase of 40.48% and a month-on-month increase of 8.60% [2] - The poultry breeding and processing segment generated chicken sales revenue of 1.36 billion yuan, up 45.11% year-on-year, but down 1.80% month-on-month [2] - The deep-processed meat products segment reported sales revenue of 1.106 billion yuan, reflecting a year-on-year increase of 52.76% and a month-on-month increase of 16.72% [2] Sales Volume - The sales volume for chicken in the poultry breeding and processing segment was 133,700 tons, marking a year-on-year increase of 42.79% and a month-on-month decrease of 9.40% [2] - The sales volume for deep-processed meat products was 55,000 tons, which is a year-on-year increase of 54.48% and a month-on-month increase of 11.78% [2] Operational Insights - The increase in actual production days in January due to the Spring Festival led to significant year-on-year fluctuations in sales volume and operational data, with expectations for cumulative data in January-February to return to normal levels [3] - The company continues to leverage its integrated industry chain advantages, focusing on refined cost control and systematic improvements in production efficiency, resulting in a further year-on-year decrease in comprehensive meat production costs [3] - Ongoing optimization of high-value channels and product structures has effectively enhanced the company's profitability resilience and stability [3]

证券代码：002716 证券简称：湖南白银 公告编号：2026-020 湖南白银股份有限公司 关于持股5%以上股东减持计划实施完毕的公告 登录新浪财经APP 搜索【信披】查看更多考评等级 股东郴州市国资控股集团有限公司保证向本公司提供的信息内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 2025年10月18日，湖南白银股份有限公司（以下简称"公司"）披露了《关于持股5%以上股东减持股份 预披露公告》（公告编号2025-078），公司持股5%以上股东郴州市国资控股集团有限公司（曾用 名："郴州市发展投资集团产业投资经营有限公司"，以下简称"郴州国控"）计划自2025年10月18日起十 五个交易日后的三个月内（即从2025年11月10日起至2026年2月9日止），减持股份数量不超过 56,460,000股（不超过公司总股本的2%），其中以集中竞价方式减持公司股份不超过28,230,000股（不 超过公司总股本的1%），以大宗交易方式减持公司股份不超过 28,230,000股（不超过公司总股本的 1%）。 2025年12月31日，公司 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：600589 证券简称：大位科技 公告编号：2026-006 2、本次质押股份不存在被用作重大资产重组业绩补偿等事项的担保或其他保障用途。 3、股东累计质押股份情况 大位数据科技（广东）集团股份有限公司 关于控股股东部分股份被质押的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 大位数据科技（广东）集团股份有限公司（以下简称"公司"）控股股东北京城市智算信息产业合伙企 业（有限合伙）（以下简称"城市智算"）持有公司股份230,000,000股，占公司总股本的15.49%。城市智 算本次质押公司股票35,900,000股，占其持股数量的比例为15.61%，占公司总股本的2.42%。 一、本次股份质押情况 公司于2026年2月10日获悉公司控股股东城市智算所持有本公司的部分股份被质押，具体情况如下： 1、本次股份质押基本情况 ■ 截至本公告披露日，城市智算累计质押股份情况如下： ■ 二、其他事项 城市智算资信状况良好，具备相应的资金偿还能力，其所 ...

Core Viewpoint - The announcement details the partial pledge and release of shares by the controlling shareholder of Lianmei Quantum Co., Ltd., indicating a stable financial situation and manageable risks associated with the pledged shares [2][5]. Group 1: Share Pledge and Release Details - The controlling shareholder, Lianzhong New Energy Co., Ltd., holds a total of 1,198,817,284 shares, representing 52.98% of the company's total equity. A total of 122,000,000 shares were pledged, while 135,000,000 shares were released from pledge [2][3]. - After the pledge and release, Lianzhong New Energy has a cumulative pledge of 453,780,000 shares, which is 37.85% of its total holdings [2][3]. Group 2: Cumulative Pledge Situation - Lianzhong New Energy and its concerted party, Lianmei Group Co., Ltd., collectively hold 1,588,777,742 shares, accounting for 70.21% of the company's issued shares. The total number of pledged shares is 604,980,000, which is 26.74% of the total equity and 38.08% of their combined holdings [2][4]. Group 3: Impact on the Company - The financial status of Lianzhong New Energy is reported to be good, with adequate repayment capability. The risks associated with the pledged shares are considered controllable, and there will be no change in the actual control of the company or impact on its operations and governance [5].

Core Viewpoint - The announcement details the partial release and re-pledge of shares by the controlling shareholder of DreamNet Technology Group, highlighting the current status and implications of these actions on the company's operations and governance. Group 1: Shareholder Pledge Situation - The controlling shareholder, Yu Wensheng, has pledged shares unrelated to the company's operational needs [2] - As of the announcement date, Yu Wensheng has a total of 79,820,000 shares maturing in the next six months, representing 70.52% of his holdings and 9.91% of the company's total equity, with a corresponding financing balance of 572 million yuan [2] - In the next year, a total of 92,020,000 shares will mature, accounting for 81.30% of his holdings and 11.43% of the total equity, with a financing balance of 635 million yuan [2] Group 2: Financial Health and Risk Management - Yu Wensheng does not have any non-operational fund occupation or illegal guarantees that would harm the interests of the listed company [3] - The current share pledge situation is not expected to adversely affect the company's operations or governance, and there are no performance compensation obligations for the controlling shareholder [3] - The controlling shareholder has a good credit status and repayment capability, with no significant litigation or arbitration related to debt issues [5] Group 3: Future Considerations - The current pledged shares do not pose a risk of forced liquidation, and the company will continue to monitor the situation closely [5][6] - If the company's stock price experiences significant volatility, there may be a risk of default leading to share disposal, and the company will ensure timely information disclosure [5]

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：001308 证券简称：康冠科技 公告编号：2026-001 深圳市康冠科技股份有限公司关于为全资子公司提供担保的进展公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、误导性陈述或重大遗 漏。 特别风险提示： 1、本次被担保对象惠州市康冠科技有限公司资产负债率超过70%； 2、公司及下属全资或控股子公司担保金额（均为公司合并报表范围内主体之间的担保）超过上市公司 最近一期经审计净资产50%。 敬请投资者注意相关风险。 一、担保情况概述 深圳市康冠科技股份有限公司（以下简称"公司""上市公司"或"康冠科技"）于2025年8月25日、2025年 10月15日分别召开了第二届董事会第三十次会议、2025年第二次临时股东大会，审议通过了《关于2025 年度公司及子公司提供担保额度预计的议案》，同意公司为子公司提供担保、子公司之间互相担保及子 公司对上市公司提供担保额度总计不超过等值人民币800,000.00万元。担保额度有效期为自审议本议案 的股东大会决议通过之日起12个月。 其中，公司下属全资子公司惠州市康冠科技有限公司（以下简 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：688172 证券简称：燕东微 公告编号：2026-011 北京燕东微电子股份有限公司关于持股5%以上股东减持股份至5%的权益变动提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、本次权益变动基本情况 （一）信息披露义务人的基本情况 ■ （二）本次权益变动的基本情况 2026年1月6日至2026年2月10日，国家集成电路基金因自身资金需求通过集中竞价交易方式减持公司股 份。具体情况如下： ■ （三）本次权益变动前后，信息披露义务人拥有上市公司权益的股份变动情况 ● 本次权益变动为北京燕东微电子股份有限公司（以下简称"公司"）股东国家集成电路产业投资基金股 份有限公司（以下简称"国家集成电路基金""信息披露义务人"）减持股份，不触及要约收购； ● 本次权益变动后，公司股东国家集成电路基金合计持有的公司股份由86,747,202减少至71,380,905股， 持有公司股份比例由6.08%减少至5.00%，不再是公司持股5%以上股东； ● 本次 ...